Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/23/2007US20070197607 Continuous Dosing Regimen
08/23/2007US20070197606 Use of ppar agonists as anti-oxidants
08/23/2007US20070197605 2-[3-(5-Methyl-2-m-tolyloxazol-4-ylmethoxymethyl)cyclohexylcarbamoyl]cyclobutanecarboxylic acid; modulation and control lipid and/or carbohydrate metabolism
08/23/2007US20070197604 3-Methyl-6-(4-{5-methyl-4-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-oxazol-2-yl}-phenyl)-pyridazine; for treatment of obesity, cognitive deficiencies, narcolepsy
08/23/2007US20070197603 Substituted indole ligands for the orl-1 receptor
08/23/2007US20070197602 Combined pharmaceutical composition
08/23/2007US20070197601 Use of N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives in therapy
08/23/2007US20070197600 Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
08/23/2007US20070197599 Hydroxylamines and derivatives as anti-angiogenic agents
08/23/2007US20070197598 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/23/2007US20070197597 Process for the preparation of tryptase inhibitors
08/23/2007US20070197596 5-HT 2A antagonists; psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's, Huntington's, eating disorders, sleep apnoea, premenstrual syndrome; obsessive-compulsive disorder (OCD);
08/23/2007US20070197595 Benzisoxazoles
08/23/2007US20070197594 Cyclic amine derivative or salt thereof
08/23/2007US20070197593 Hydroxylamines and derivatives for treatment of inflammatory conditions of the liver
08/23/2007US20070197592 Use of Paliperidone for the Treatment of Substance Abuse
08/23/2007US20070197591 Use of paliperidone for the treatment of a mental disorder in a psychiatric patient with reduced hepatic function
08/23/2007US20070197590 Substituted dipiperidine ccr2 antagonists
08/23/2007US20070197589 Cyclic quaternary amino derivatives as modulators of chemokine receptors
08/23/2007US20070197588 Tetralone-based monoamine reuptake inhibitors
08/23/2007US20070197587 Quinoline Derivatives as CRTH2 Antagonists
08/23/2007US20070197586 8-Hydroxy-5-[(-Hydroxy-2-[[ (1R)-2-(4-Methoxyphenyl)-1-Methylethyl] Amino][Ethyl]-2(1H)-Quinolinone Monohydrochloride In Crystalline Form And The Process For Its Preparation
08/23/2007US20070197585 Use of cysteinyl leukotriene 2 receptor antagonists
08/23/2007US20070197584 Diabetes, obesity; melanin-concentrating hormone receptor 1 antagonists
08/23/2007US20070197583 Novel compositions and methods for modulation of the acid-sensing ion channel (ASIC) for the treatment of anxiety and drug addiction
08/23/2007US20070197582 Imidazo[[1, 5-a] pyridine derivatives and methods for treating aldosterone mediated diseases
08/23/2007US20070197581 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
08/23/2007US20070197580 To treat irritable bowel syndrome; side effect reduction, improved pharmacodynamics and safety, more potent and selective; 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group
08/23/2007US20070197579 Heteroaryl-Substituted Diazatricycloalkanes and Methods of Use Thereof
08/23/2007US20070197578 Control agent containing n-substituted indole derivative for acarian parasitic on animal
08/23/2007US20070197577 Inhibitors of anthrax lethal factor
08/23/2007US20070197576 Production of Cabergoline and Novel Polymorphic Form Thereof
08/23/2007US20070197575 Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
08/23/2007US20070197574 Methods and compositions for predicting irinotecan toxicity
08/23/2007US20070197573 Compositions and methods in the treatment of bone metabolic disorders
08/23/2007US20070197572 Oxycodone polymorphs
08/23/2007US20070197571 Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer' s disease
08/23/2007US20070197570 Indanol derivative
08/23/2007US20070197569 Method for treating central nervous system disorders with substituted 2-imidazoline derivatives
08/23/2007US20070197568 Methods of using SAHA and Erlotinib for treating cancer
08/23/2007US20070197567 Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
08/23/2007US20070197566 Novel pyrazolylquinazolinones as potassium channel openers
08/23/2007US20070197565 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
08/23/2007US20070197564 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
08/23/2007US20070197563 Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase
08/23/2007US20070197562 Remedies for prostatic hypertrophy
08/23/2007US20070197561 Inhibitors of nucleoside metabolism
08/23/2007US20070197560 cGMP PDE 5 inhibitors for inhalation in the treatment of sexual dysfunction
08/23/2007US20070197559 Aryl substituted purine analogues
08/23/2007US20070197558 Anti-viral compounds
08/23/2007US20070197555 Pyrimidinone Compounds As Calcilytics
08/23/2007US20070197554 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
08/23/2007US20070197552 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
08/23/2007US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome
08/23/2007US20070197550 Histone deacetylase inhibitors for enhancing activity of antifungal agents
08/23/2007US20070197549 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
08/23/2007US20070197548 Fluoroquinolone compositions
08/23/2007US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone
08/23/2007US20070197546 Quinoline-4-carboxamide as nk-2 and nk-3 receptor antagonists
08/23/2007US20070197545 Crystalline Polymorphs Of Methanesulfonic Acid Addition Salts Of Imatinib
08/23/2007US20070197544 Iloprost in combination therapies for the treatment of pulmonary arterial hypertension
08/23/2007US20070197543 Use of derivatives of 2, 5-dihydroxyb enzene-sulphonic acids in the elaboration of a medicinal product to enhance the effect of other drugs used for the treatment of erectile dysfunction
08/23/2007US20070197542 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation
08/23/2007US20070197541 Biaryl heterocyclic amines,amides, and sulfur-containing compounds and methods of making and using the same
08/23/2007US20070197539 Hexahydro-pyrazino[1,2-a]pyrimidine-4,7-dione derivatives substituted with amino acids
08/23/2007US20070197538 Anti-vascular and anti-proliferation methods, therapies, and combinations employing specific tyrosine kinase inhibitors
08/23/2007US20070197537 Heterobicyclic thiophene compounds and methods of use
08/23/2007US20070197536 Pyridazin-3(2)-one derivatives and their use as pde4 inhibitors
08/23/2007US20070197535 Polymorphic forms of vardenafil
08/23/2007US20070197534 3-ethyl-6-[3-(4-morpholinyl)propoxy]-1,2,4-benzotriazine 1,4-dioxide; for treating cancer; radiosensitising in a subject tumor cells of solid tumors in hypoxic conditions
08/23/2007US20070197533 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds
08/23/2007US20070197532 Glucokinase activators
08/23/2007US20070197531 Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors
08/23/2007US20070197530 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
08/23/2007US20070197529 Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard
08/23/2007US20070197528 analgesic. especially acute, chronic and/or neuropathic pain; epilepsy and other CNS-related disorders as well as for neuroprotection or cardioprotection; 9-benzyl-8-(cyclopentylamine)-6-(4-nitrobenzyl-mercaptopurine
08/23/2007US20070197527 Bicyclic heteroaromatic compounds
08/23/2007US20070197526 Pyrazoles for the treatment of obesity and other CNS disorders
08/23/2007US20070197525 Novel tetracyclic tetrahydrofuran derivatives
08/23/2007US20070197524 Fluorenes and carbazoles as ligands of the EP2 receptor
08/23/2007US20070197523 Calcium channel antagonists
08/23/2007US20070197522 Dpp-iv inhibitors
08/23/2007US20070197521 Novel bicyclic heterocycles useful as selective androgen receptor modulators
08/23/2007US20070197520 Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses
08/23/2007US20070197519 New Process For The Preparation Of Oxabispidines
08/23/2007US20070197518 particularly for the treatment of infections caused by resistant strains of bacteria; 9,10- difluoro-2,4-dimethyl-8-pyrazin-2-yl-1,2,4,4a- tetrahydro-2'H,6H- spiro[1,4-oxazino[4,3-a]quinoline-5,5'- pyrimidine]- 2',4',6'(1'H,3'H)-trione
08/23/2007US20070197517 Combination therapy for hyperproliferative disease
08/23/2007US20070197516 modulators of monocyte chemotactic proteins (MCP-1), such as N-(2-(((S)-1-((2S,3S)-3-hydroxy-1-(isobutylamino)hexan-2-yl)-2-oxopyrrolidin-3-yl)carbamoyl)-4-(trifluoromethyl)phenyl)azetidine-1-carboxamide, useful for the prevention of asthma, multiple sclerosis, atherosclerosis and rheumatoid arthritis
08/23/2007US20070197515 lanthionine ketimine derivatives and thiomorpholine dicarboxylic acid derivatives; can pass through blood-brain barrier; has -oxidant, anti-neuroinflammatory and neuroprotective activities; cancer,Parkinson's disease, Huntington's disease, multiple sclerosis
08/23/2007US20070197514 Conjugates with organic acids; uses thereof in the treatment of psychotic and/or proliferative disorders and diseases and as chemosensitizing agents; the organic acids are selected to reduce side effects induced by the psychotropic drugs and/or to exert an anti-proliferative activity
08/23/2007US20070197513 calcium channel modulator; [[1-(4-{2-[1-(4-Chloro-phenyl)-2-(2-methoxy-phenyl)-1H-imidazol-4-yl]-ethyl}-(4-fluoro-phenyl)-methyl-amine; analgesic, antidiabetic agent; angina, hypertension, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders
08/23/2007US20070197512 Carboxylic Acid Compounds and Use Thereof
08/23/2007US20070197511 Neuroprotective bicyclic compouds and methods for their use
08/23/2007US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient
08/23/2007US20070197509 Compositions and methods for modulating gated ion channels
08/23/2007US20070197508 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
08/23/2007US20070197507 N-Heteroaryl-N'-(1-(piperazin-1-yl)-6 or 7-indanyl)ureas, e.g., methyl 4-(6-{[(6-methyl-3-pyridyl)amino]carbonylamino}indanyl)piperazinecarboxylate and N-{3-[4-(ethylsulfonyl)piperazinyl]indan-5-yl}[(6-methyl(3-pyridyl))amino]carboxamide; cardiac myosin potentiators; treating congestive heart failure
08/23/2007US20070197506 Modulators of 11-beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
08/23/2007US20070197505 Certain chemical entities, compositions and methods
08/23/2007US20070197504 tert-butyl 4-{[3-({[(6-methyl-3-pyridyl)amino]carbonylamino}methyl)phenyl]methyl}-piperazinecarboxylate; selectively modulates the cardiac sarcomere, for example by potentiating cardiac myosin, and may be useful in the treatment of systolic heart failure including congestive heart failure
1 ... 3613 3614 3615 3616 3617 3618 3619 3620 3621 3622 3623 3624 3625 3626 3627 3628 3629 3630 3631 3632 3633 ... 7860